Pascale Bonnafous
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Pascale Bonnafous has a total of 166 co-authors. Here are the top co-authors by number of shared publications:
Henri Agut
AP-HP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Service de Virologie, Paris, France
17 shared publicationsAgnès Gautheret-Dejean
12 shared publicationsDavid Boutolleau
UPMC Univ Paris 06; ER1 DETIV; Paris F-75013 France
10 shared publicationsH. Agut
Sorbonne Université, Faculté de médecine, INSERM, CIMI-Paris U1135, Equipe PVI, F-75013 Paris, France
9 shared publicationsA. Gautheret-Dejean
CIMI-Paris UMRS CR7, Inserm U1135, Equipe 1 Infections Virales Persistantes, Faculté de médecine, Sorbonne Université, Paris, France
8 shared publications- Agnès Gautheret-Dejean
AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Service de Virologie, Paris, France
6 shared publications
Latest Publications
- Open Access
- 28 June 2021
- Published by EDP Sciences in médecine/sciences
- Vol. 37 (6-7) , 578-581
Rôle des herpèsvirus humains 6 (HHV-6) dans la prédisposition à la pré-éclampsie
Médecine/sciences (M/S), revue internationale dans le domaine de la recherche biologique, médicale et en santé
- 28 June 2021
- Published by EDP Sciences in médecine/sciences
- Vol. 37 (6-7) , 578-581
Open AccessRôle des herpèsvirus humains 6 (HHV-6) dans la prédisposition à la pré-éclampsie
Médecine/sciences (M/S), revue internationale dans le domaine de la recherche biologique, médicale et en santé
- 3 October 2019
- Published by Wiley in Journal of Medical Virology
- Vol. 92 (2) , 241-250
Evaluation of liver failure in a pediatric transplant recipient of a liver allograft with inherited chromosomally integrated HHV‐6B
Background: Active infections of human herpesvirus 6B (HHV‐6B) are frequent in immunocompromised recipients after transplantation. Nevertheless, they need to be distinguished from latent inherited chromosomally integrated genomes (iciHHV‐6) present in about 1% of the population to avoid unnecessary administration of toxic antivirals.Methods: A 5‐year‐old child presented with acute liver allograft rejection associated with HHV‐6 DNA in plasma, which led to an unfavorable outcome. We investigated the possibility of HHV‐6 infection derived from an iciHHV‐6 present in the donor's liver using molecular and histopathology studies in various tissues, including quantification of HHV‐6 DNA, genotyping, sequencing for antiviral resistance genes, relative quantification of viral transcripts, and detection of gB and gH viral proteins.Results: The presence of iciHHV‐6B was evidenced in the donor with signs of reactivation in the gallbladder and transplanted liver (detection of HHV‐6B mRNA and late proteins). This localized expression could have played a role in liver rejection. Low viral loads in the recipient's plasma, with identical partial U39 sequences, were in favor of viral DNA released from the transplanted liver rather than a systemic infection.Conclusions: Determination of iciHHV‐6 status before transplantation should be considered to guide clinical decisions, such as antiviral prophylaxis, viral load monitoring, and antiviral therapy.
- 3 October 2019
- Published by Wiley in Journal of Medical Virology
- Vol. 92 (2) , 241-250
Evaluation of liver failure in a pediatric transplant recipient of a liver allograft with inherited chromosomally integrated HHV‐6B
Background: Active infections of human herpesvirus 6B (HHV‐6B) are frequent in immunocompromised recipients after transplantation. Nevertheless, they need to be distinguished from latent inherited chromosomally integrated genomes (iciHHV‐6) present in about 1% of the population to avoid unnecessary administration of toxic antivirals.Methods: A 5‐year‐old child presented with acute liver allograft rejection associated with HHV‐6 DNA in plasma, which led to an unfavorable outcome. We investigated the possibility of HHV‐6 infection derived from an iciHHV‐6 present in the donor's liver using molecular and histopathology studies in various tissues, including quantification of HHV‐6 DNA, genotyping, sequencing for antiviral resistance genes, relative quantification of viral transcripts, and detection of gB and gH viral proteins.Results: The presence of iciHHV‐6B was evidenced in the donor with signs of reactivation in the gallbladder and transplanted liver (detection of HHV‐6B mRNA and late proteins). This localized expression could have played a role in liver rejection. Low viral loads in the recipient's plasma, with identical partial U39 sequences, were in favor of viral DNA released from the transplanted liver rather than a systemic infection.Conclusions: Determination of iciHHV‐6 status before transplantation should be considered to guide clinical decisions, such as antiviral prophylaxis, viral load monitoring, and antiviral therapy.
- Open Access
- 9 July 2018
- Published by Elsevier in American Journal of Transplantation
- Vol. 19 (1) , 304-305
Need for a better characterization of HHV-6 infections and associated clinical impacts
- 9 July 2018
- Published by Elsevier in American Journal of Transplantation
- Vol. 19 (1) , 304-305
Open AccessNeed for a better characterization of HHV-6 infections and associated clinical impacts
- Open Access
- 1 June 2018
- Published by Elsevier in American Journal of Transplantation
- Vol. 18 (6) , 1548-1551
Fatal outcome after reactivation of inherited chromosomally integrated HHV-6A (iciHHV-6A) transmitted through liver transplantation
- 1 June 2018
- Published by Elsevier in American Journal of Transplantation
- Vol. 18 (6) , 1548-1551
Open AccessFatal outcome after reactivation of inherited chromosomally integrated HHV-6A (iciHHV-6A) transmitted through liver transplantation
- 6 April 2017
- Published by S. Karger AG in Gynecologic and Obstetric Investigation
- Vol. 82 (3) , 307-310
Vaginal Neoplasia Induced by an Unusual Papillomavirus Subtype in a Woman with Inherited Chromosomally Integrated Human Herpesvirus Type 6A
We describe here a case of high-grade vaginal squamous lesion in a 54-year-old woman with a papillomaviruses (HPV) genital infection that developed from a cervical low-grade squamous intraepithelial lesion (SIL) to a high-grade SIL (H-SIL) on cytological examination. A colposcopy exam led to the detection of suspect vaginal lesions with granulomatous infiltrations, which were classified as a Vaginal Intra-Epithelial Neoplasia grade 2 after pathologists' analyses. After a laser vaginal surgery and a loop excision of the transformation zone, the analyses of the anatomical pieces using a near-complete HPV screening panel revealed an HPV-4 infection that was not detected before in cervical smears. This HPV-infection is associated with a high human herpesvirus type 6A (HHV-6A) viral load in the same anatomical piece. The presence of an inherited chromosomally integrated HHV-6A (iciHHV-6A) was proved in this patient by real-time polymerase chain reaction on hair follicles and nail. This case suggests reconsidering both the benign nature of low-grade lesions in the female genital tract and the well-known “good” prognosis of low-risk HPV infection, especially when iciHHV-6A is diagnosed. This clinical course insists on the benefits of the multiplex panel use or global sequencing in order to optimize biological testing sensitivity, and so enhance clinical management of infection-induced neoplasia.
- 6 April 2017
- Published by S. Karger AG in Gynecologic and Obstetric Investigation
- Vol. 82 (3) , 307-310
Vaginal Neoplasia Induced by an Unusual Papillomavirus Subtype in a Woman with Inherited Chromosomally Integrated Human Herpesvirus Type 6A
We describe here a case of high-grade vaginal squamous lesion in a 54-year-old woman with a papillomaviruses (HPV) genital infection that developed from a cervical low-grade squamous intraepithelial lesion (SIL) to a high-grade SIL (H-SIL) on cytological examination. A colposcopy exam led to the detection of suspect vaginal lesions with granulomatous infiltrations, which were classified as a Vaginal Intra-Epithelial Neoplasia grade 2 after pathologists' analyses. After a laser vaginal surgery and a loop excision of the transformation zone, the analyses of the anatomical pieces using a near-complete HPV screening panel revealed an HPV-4 infection that was not detected before in cervical smears. This HPV-infection is associated with a high human herpesvirus type 6A (HHV-6A) viral load in the same anatomical piece. The presence of an inherited chromosomally integrated HHV-6A (iciHHV-6A) was proved in this patient by real-time polymerase chain reaction on hair follicles and nail. This case suggests reconsidering both the benign nature of low-grade lesions in the female genital tract and the well-known “good” prognosis of low-risk HPV infection, especially when iciHHV-6A is diagnosed. This clinical course insists on the benefits of the multiplex panel use or global sequencing in order to optimize biological testing sensitivity, and so enhance clinical management of infection-induced neoplasia.
- 1 March 2017
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 47 (2) , 83-91
Update on infections with human herpesviruses 6A, 6B, and 7
- 1 March 2017
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 47 (2) , 83-91
Update on infections with human herpesviruses 6A, 6B, and 7
- 6 May 2016
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 4 (3) , 157-176
Human Herpesviruses 6A, 6B, and 7
Human roseoloviruses include three different species, human herpesviruses 6A, 6B, and 7 (HHV-6A, HHV-6B, HHV-7), genetically related to human cytomegalovirus. They exhibit a wide cell tropismin vivoand, like other herpesviruses, induce a lifelong latent infection in humans. In about 1% of the general population, HHV-6 DNA is covalently integrated into the subtelomeric region of cell chromosomes (ciHHV-6). Many active infections, corresponding to primary infections, reactivations, or exogenous reinfections, are asymptomatic. They also may cause serious diseases, particularly in immunocompromised individuals, including hematopoietic stem-cell transplant (HSCT) and solid-organ transplant recipients, and acquired immunodeficiency syndrome (AIDS) patients. This opportunistic pathogenic role is formally established for HHV-6 infection and less clear for HHV-7. It mainly concerns the central-nervous system, bone marrow, lungs, gastrointestinal tract, skin, and liver. As the best example, HHV-6 causes both exanthema subitum, a benign disease associated with primary infection, and severe encephalitis associated with virus reactivations in HSCT recipients. Diagnosis using serologic and direct antigen-detection methods currently exhibits limitations. The most prominent technique is the quantification of viral DNA in blood, other body fluids, and organs by means of real-time polymerase-chain reaction (PCR). The antiviral compounds ganciclovir, foscarnet, and cidofovir are effective against active infections, but there is currently no consensus regarding the indications of treatment or specifics of drug administration. Numerous questions about HHV-6A, HHV-6B, HHV-7 are still pending, concerning in particular clinical impact and therapeutic options in immunocompromised patients.
- 6 May 2016
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 4 (3) , 157-176
Human Herpesviruses 6A, 6B, and 7
Human roseoloviruses include three different species, human herpesviruses 6A, 6B, and 7 (HHV-6A, HHV-6B, HHV-7), genetically related to human cytomegalovirus. They exhibit a wide cell tropismin vivoand, like other herpesviruses, induce a lifelong latent infection in humans. In about 1% of the general population, HHV-6 DNA is covalently integrated into the subtelomeric region of cell chromosomes (ciHHV-6). Many active infections, corresponding to primary infections, reactivations, or exogenous reinfections, are asymptomatic. They also may cause serious diseases, particularly in immunocompromised individuals, including hematopoietic stem-cell transplant (HSCT) and solid-organ transplant recipients, and acquired immunodeficiency syndrome (AIDS) patients. This opportunistic pathogenic role is formally established for HHV-6 infection and less clear for HHV-7. It mainly concerns the central-nervous system, bone marrow, lungs, gastrointestinal tract, skin, and liver. As the best example, HHV-6 causes both exanthema subitum, a benign disease associated with primary infection, and severe encephalitis associated with virus reactivations in HSCT recipients. Diagnosis using serologic and direct antigen-detection methods currently exhibits limitations. The most prominent technique is the quantification of viral DNA in blood, other body fluids, and organs by means of real-time polymerase-chain reaction (PCR). The antiviral compounds ganciclovir, foscarnet, and cidofovir are effective against active infections, but there is currently no consensus regarding the indications of treatment or specifics of drug administration. Numerous questions about HHV-6A, HHV-6B, HHV-7 are still pending, concerning in particular clinical impact and therapeutic options in immunocompromised patients.
- 1 March 2016
- Published by JLE in Annales de biologie clinique
- Vol. 74 (2) , 156-167
Diagnosis and practice of virological monitoring of infections by the human herpesviruses 6A and 6B
The diagnosis of the infection by the human herpesviruses 6A and 6B (HHV-6A, HHV-6B) is based on a direct and an indirect approaches. Serological methods are mainly used to ask primary infection diagnosis and carry out epidemiological studies. However, limitations are numerous with, in particular, the existence of cross-reactivity with other herpesviruses, and the inability to differentiate the two kinds of HHV-6. Initially based on virus isolation in cell culture, direct diagnosis evolved with the development of gene amplification methods that provide sensitivity and specificity, and allow viral quantitation in many biological systems and the identification of present species. Its main current indications are the identification of active infection, the identification of the integrated form of HHV-6 (iciHHV-6, inherited chromosomally integrated HHV-6) and the monitoring of the effectiveness of antiviral treatment.
- 1 March 2016
- Published by JLE in Annales de biologie clinique
- Vol. 74 (2) , 156-167
Diagnosis and practice of virological monitoring of infections by the human herpesviruses 6A and 6B
The diagnosis of the infection by the human herpesviruses 6A and 6B (HHV-6A, HHV-6B) is based on a direct and an indirect approaches. Serological methods are mainly used to ask primary infection diagnosis and carry out epidemiological studies. However, limitations are numerous with, in particular, the existence of cross-reactivity with other herpesviruses, and the inability to differentiate the two kinds of HHV-6. Initially based on virus isolation in cell culture, direct diagnosis evolved with the development of gene amplification methods that provide sensitivity and specificity, and allow viral quantitation in many biological systems and the identification of present species. Its main current indications are the identification of active infection, the identification of the integrated form of HHV-6 (iciHHV-6, inherited chromosomally integrated HHV-6) and the monitoring of the effectiveness of antiviral treatment.
- 1 February 2016
- Published by Elsevier in Journal of Infection
- Vol. 72 (2) , 214-222
HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns
- 1 February 2016
- Published by Elsevier in Journal of Infection
- Vol. 72 (2) , 214-222
HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns